Cotrimoxazole ups hyperkalaemia risk in elderly receiving spironolactone Clinical study 14 January 2013 Pages: 1 - 1
The EMA's Pharmacovigilance Working Party (PhVWP) recommends that the labelling for all antipsychotics should be updated News item 14 January 2013 Pages: 2 - 2
The EMA's CHMP has adopted changes to the labelling of Sprycel [dasatinib] regarding to risk of pulmonary arterial hypertension (PAH). News item 14 January 2013 Pages: 2 - 2
Fluoroquinolones linked with myasthenia gravis exacerbation Incidence study 14 January 2013 Pages: 4 - 4